Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BofA Securities Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 6:52 AM EDTBofA Securities analyst Travis Steed initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Wolfe Research Starts Kestra Medical Technologies (KMTS) at Outperform
March 31, 2025 5:19 AM EDTWolfe Research analyst Mike Polark initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
March 31, 2025 5:12 AM EDTGoldman Sachs analyst David Roman initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Neutral rating and a price target of $24.00.
The analyst comments "We initiate coverage on the shares of Kestra Medical Technologies (KMTS) with a Neutral rating and a 12-month price target... More
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
March 31, 2025 3:55 AM EDTPiper Sandler analyst Matt O\'Brien initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Overweight rating and a price target of $27.00.
The analyst comments: "We are initiating Kestra Medical with an OW rating and $27 price target. The company boasts a unique, wearable... More
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 2:07 AM EDTStifel analyst Rick Wise initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $28.00.
The analyst comments: "We are initiating coverage of Kestra (KMTS) with a Buy rating and $28 target price. This assumes KMTS trades at 9x our CY2027E... More
